Automatic control versus Target controlled infusion . During liver Resection among Cirrhotic Patients
Phase 4
Recruiting
- Conditions
- Anaesthesia
- Registration Number
- PACTR201907882088179
- Lead Sponsor
- national liver institute
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
1.Adult liver cirrhotic patients aged 18 to 70 year undergoing liver resection.
2. American Society of Anaesthesiologists physical status class I-II
3. Child Pugh Classification A or B
Exclusion Criteria
1.Any central nervous system disease.
2.Severe haemodynamic instability during surgery.
3.Patients in need for re-operation.
4.Unwilling to participate in the study.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie automatic control of inhalational anesthetics in cirrhotic patients during liver resection?
How does automatic end-tidal control compare to propofol TCI in managing hemodynamics during hepatic surgery in cirrhosis?
Are there specific biomarkers that predict optimal response to inhalational anesthetic strategies in liver disease patients?
What adverse events are associated with target-controlled infusion of propofol in cirrhotic individuals undergoing resection?
How do alternative anesthetic regimens like sevoflurane or desflurane compare to propofol TCI in cirrhosis-related liver resection trials?